z-logo
open-access-imgOpen Access
About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use
Author(s) -
Fabienne Hartmann-Fritsch,
Daniela Marino,
Ernst Reichmann
Publication year - 2016
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000447645
Subject(s) - medicine , pig skin , clinical trial , intensive care medicine , pathology , biomedical engineering
The treatment of severe full-thickness skin defects represents a significant and common clinical problem worldwide. A bio-engineered autologous skin substitute would significantly reduce the problems observed with today's gold standard.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom